EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses

Victoria R Sanders, Neil S Millar

Pharmacological Research · 2023

DOI: 10.1016/j.phrs.2023.106759 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2023. Verfasst von Victoria R Sanders und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biosciences, University College London, London WC1E 6BT, United Kingdom. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Receptors, Nicotinic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Considerable progress has been made in recent years towards the identification and characterisation of novel subtype-selective modulators of nicotinic acetylcholine receptors (nAChRs). In particular, this has focussed on modulators of α7 nAChRs, a nAChR subtype that has been identified as a target for drug discovery in connection with a range of potential therapeutic applications. This review focusses upon α7-selective modulators that bind to receptor sites other than the extracellular 'orthosteric' agonist binding site for the endogenous agonist acetylcholine (ACh). Such compounds include those that are able to potentiate responses evoked by orthosteric agonists such as ACh (positive allosteric modulators; PAMs) and those that are able to activate α7 nAChRs by direct allosteric activation in the absence of an orthosteric agonist (allosteric agonists or 'ago-PAMs'). There has been considerable debate about the mechanism of action of α7-selective PAMs and allosteric agonists, much of which has centred around identifying the location of their binding sites on α7 nAChRs. Based on a variety of experimental evidence, including recent structural data, there is now clear evidence indicating that at least some α7-selective PAMs bind to an inter-subunit site located in the transmembrane domain. In contrast, there are differing hypotheses about the site or sites at which allosteric agonists bind to α7 nAChRs. It will be argued that the available evidence supports the conclusion that direct allosteric activation by allosteric agonists/ago-PAMs occurs via the same inter-subunit transmembrane site that has been identified for several α7-selective PAMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorReceptors, NicotinicAllosteric RegulationBinding SitesAcetylcholine

Stichwörter der Autor:innen

Acetylcholine receptorAllosteric agonistAllosteric modulationBinding siteNicotinic acetylcholine receptorPositive allosteric modulator

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorReceptors, NicotinicAcetylcholine

Autor:innen und Institutionen

  • Division of Biosciences, University College London, London WC1E 6BT, United Kingdom.
  • Division of Biosciences, University College London, London WC1E 6BT, United Kingdom. Electronic address: n.millar@ucl.ac.uk.

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Sanders, V. R., & Millar, N. S. (2023). Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.106759

Vancouver

Sanders VR, Millar NS. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses. Pharmacological Research. 2023. doi:10.1016/j.phrs.2023.106759

BibTeX
@article{Sanders2023,
  author = {Sanders, Victoria R and Millar, Neil S},
  title = {Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses},
  journal = {Pharmacological Research},
  year = {2023},
  doi = {10.1016/j.phrs.2023.106759}
}
Kostenlos starten →